| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	New technology has potential to accelerate timelines for therapeutic research and drug developmentTelesis Bio Inc. (OTC:TBIO), ...
 
																	
 
																	
 
																	
 
																	
 
																	Telesis Bio shares are moving higher on Thursday after the company announced a partnership with Beckman Coulter Life Sciences.
 
																	
 
																	
